Global Hepatitis C Drugs Market 2021-2025

Global Hepatitis C Drugs Market 2021-2025

Technavio has been monitoring the hepatitis C drugs market and it is poised to grow by $ 252.89 mn during 2021-2025 progressing at a CAGR of 1% during the forecast period. Our report on hepatitis C drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for direct-acting antivirals and rising number of patient support initiatives. In addition, increasing demand for direct-acting antivirals is anticipated to boost the growth of the market as well.

The hepatitis C drugs market analysis includes product segments and geographical landscapes.

Technavio's hepatitis C drugs market is segmented as below:

By Product

  • Combination therapy
  • Monotherapy
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the high prevalence of hepatitis C as one of the prime reasons driving the hepatitis C drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis C drugs market covers the following areas:
  • Hepatitis C drugs market sizing
  • Hepatitis C drugs market forecast
  • Hepatitis C drugs market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis c drugs market vendors that include AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Co., Cipla Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., and Vertex Pharmaceuticals Inc. Also, the hepatitis c drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
    • Market Characteristics
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis: Pharmaceuticals market
      • Research and development (R&D) and drug discovery
      • Integration and product development
      • Manufacturing
      • Outbound logistics
      • Marketing and sales
      • Support services
      • Innovation
  • Market Sizing
    • Market definition
      • Acute hepatitis C
      • Chronic hepatitis C
        • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
      • Table Global - Market size and forecast 2020 - 2025 ($ million)
      • Table Global market: Year-over-year growth 2020 - 2025 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2020 & 2025
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2020
  • Market Segmentation by Product
    • Market segments
      • Table Product - Market share 2020-2025 (%)
    • Comparison by Product
      • Table Comparison by Product
    • Combination therapy - Market size and forecast 2020-2025
      • Table Combination therapy - Market size and forecast 2020-2025 ($ million)
      • Table Combination therapy - Year-over-year growth 2020-2025 (%)
    • Monotherapy - Market size and forecast 2020- 2025
      • Table Monotherapy - Market size and forecast 2020-2025 ($ million)
      • Table Monotherapy - Year-over-year growth 2020-2025 (%)
    • Market opportunity by Product
      • Table Market opportunity by Product
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2020-2025 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2020- 2025
      • Table North America - Market size and forecast 2020-2025 ($ million)
      • Table North America - Year-over-year growth 2020-2025 (%)
    • Europe - Market size and forecast 2020-2025
      • Table Europe - Market size and forecast 2020-2025 ($ million)
      • Table Europe - Year-over-year growth 2020-2025 (%)
    • Asia - Market size and forecast 2020-2025
      • Table Asia - Market size and forecast 2020-2025 ($ million)
      • Table Asia - Year-over-year growth 2020-2025 (%)
    • ROW - Market size and forecast 2020-2025
      • Table ROW - Market size and forecast 2020-2025 ($ million)
      • Table ROW - Year-over-year growth 2020-2025 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Increasing demand for direct-acting antivirals
      • High prevalence of hepatitis C
      • Rising number of patient support initiatives
    • Market challenges
      • High cost of drugs
      • Poor diagnosis
      • Side effects of available drugs
        • Table Impact of drivers and challenges
    • Market trends
      • Increasing number of voluntary licensing agreements
      • Market entry of branded generics
      • Significant technological advances
  • Vendor Landscape
    • Competitive scenario
    • Vendor landscape
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Industry risks
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Business segments
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key offerings
      • Table AbbVie Inc. - Segment focus
    • Astellas Pharma Inc.
      • Table Astellas Pharma Inc. - Overview
      • Table Astellas Pharma Inc. - Business segments
      • Table Astellas Pharma Inc. –Key news
      • Table Astellas Pharma Inc. - Key offerings
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. - Overview
      • Table Bristol-Myers Squibb Co. - Business segments
      • Table Bristol-Myers Squibb Co. –Key news
      • Table Bristol-Myers Squibb Co. - Key offerings
      • Table Bristol-Myers Squibb Co. - Segment focus
    • Cipla Inc.
      • Table Cipla Inc. - Overview
      • Table Cipla Inc. - Business segments
      • Table Cipla Inc. –Key news
      • Table Cipla Inc. - Key offerings
      • Table Cipla Inc. - Segment focus
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. –Key news
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
    • Gilead Sciences Inc.
      • Table Gilead Sciences Inc. - Overview
      • Table Gilead Sciences Inc. - Business segments
      • Table Gilead Sciences Inc. –Key news
      • Table Gilead Sciences Inc. - Key offerings
      • Table Gilead Sciences Inc. - Segment focus
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc. –Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Johnson & Johnson
      • Table Johnson & Johnson - Overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson – Key news
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Segment focus
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co. Inc. –Key news
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Segment focus
    • Vertex Pharmaceuticals Inc.
      • Table Vertex Pharmaceuticals Inc. - Overview
      • Table Vertex Pharmaceuticals Inc. - Business segments
      • Table Vertex Pharmaceuticals Inc. –Key news
      • Table Vertex Pharmaceuticals Inc. - Key offerings
      • Table Vertex Pharmaceuticals Inc. - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings